News

A new report found that all combinations of primary and booster COVID-19 vaccines granted Emergency Use Authorization or approval by the Food and Drug Administration are safe and result in an immune response against SARS-CoV-2.

Researchers have developed a range of permanent hair dyes that avoid the allergenic properties of traditional formulations.

According to new data from the Francis Crick Institute and The Royal Marsden NHS Foundation Trust, nearly fifty percent of blood cancer patients do not have enough antibodies able to neutralize Omicron after a third vaccine dose.

A study has shown that transfusions of blood plasma donated by people who have already recovered from COVID-19 infection may help other hospitalized patients.

New research into how viral proteins interact and can be disabled holds promise to help plants defend themselves against viruses—and ultimately prevent crop losses.

A study has identified a new approach to attacking herpesviruses.

A new immune pathway has been discovered in chickens that viruses — such as those that tend to infect birds, humans and animals and spread diseases like influenza or Crimean-Congo hemorrhagic fever — may be targeting.

Overweight dogs fed a high-protein and high-fiber diet showed positive changes in body composition and inflammatory markers alongside weight loss.

Scientists have found that four COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2. These T cells can recognize SARS-CoV-2 Variants of Concern, including Delta and Omicron.

Scientists have explored the effect of donor selection on the establishment and long-term stability of transplanted microbiota, especially in aged hosts.